SEOUL: The Samsung group plans to raise spending by more than 30% to 450 trillion won (US$360bil or RM1.58 trillion) over the half-decade to 2026 to shore up businesses from chips to drugs, as South Korea’s conglomerates grapple with growing economic and supply shocks.
The corporate giant – whose units from Samsung Electronics Co to Samsung Biologics Co dominate South Korea’s economy – promised in a statement to create 80,000 jobs through 2026, mostly in semiconductors and biopharmaceuticals.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
